Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency department

Peter A. Kavsak(McMaster University), Andrew Worster(McMaster University), William Parsonage(Queensland University of Technology), Lauren E. Griffith(Impact), Jinhui Ma(McMaster University), Martin Than(Christchurch Hospital), Stefan Blankenberg(Universität Hamburg), Mark Richards(National University Health System), P.J. Devereaux(University of Limerick), Nils A. Sörensen(Universität Hamburg), Dirk Westermann(University Medical Center Freiburg), Richard W. Troughton(Canterbury Health Laboratories), Shamir R. Mehta(Population Health Research Institute), Francisco Ojeda(Universidad Complutense de Madrid), Louise Cullen(Royal Brisbane and Women's Hospital), Jonathan Sherbino(McMaster University Medical Centre), John W. Pickering(Christchurch Hospital), Colleen Shortt(Universität Hamburg), Jaimi Greenslade(Royal Brisbane and Women's Hospital), Sally Aldous(Christchurch Hospital), Matthew McQueen(Population Health Research Institute), Natasha Clayton(Universität Hamburg), Stephen Hill(Faraday Technology (United States)), Franz–Josef Neumann(Universitäts-Herzzentrum Freiburg-Bad Krozingen)
Canadian Medical Association Journal
August 19, 2018
Cited by 46


Related Papers